122 related articles for article (PubMed ID: 37756502)
1. Anticholinergic Burden and Xerostomia in Critical Care Settings.
Chung J; Tjia J; Zhang N; O'Connor BT
Dimens Crit Care Nurs; 2023 Nov-Dec 01; 42(6):310-318. PubMed ID: 37756502
[TBL] [Abstract][Full Text] [Related]
2. Anticholinergic burden and dry mouth among Finnish, community-dwelling older adults.
Tiisanoja A; Syrjälä AM; Komulainen K; Lampela P; Hartikainen S; Taipale H; Knuuttila M; Ylöstalo P
Gerodontology; 2018 Mar; 35(1):3-10. PubMed ID: 28940566
[TBL] [Abstract][Full Text] [Related]
3. Association between anticholinergic activity and xerostomia and/ or xerophthalmia in the elderly: systematic review.
Prado-Mel E; Ciudad-Gutiérrez P; Rodríguez-Ramallo H; Sánchez-Fidalgo S; Santos-Ramos B; Villalba-Moreno AM
BMC Pharmacol Toxicol; 2022 Dec; 23(1):94. PubMed ID: 36539885
[TBL] [Abstract][Full Text] [Related]
4. [Anticholinergic scales: Use in psychiatry and update of the anticholinergic impregnation scale].
Javelot H; Meyer G; Becker G; Post G; Runge V; Pospieszynski P; Schneiderlin T; Armand-Branger S; Michel B; Weiner L; Faria CGF; Drapier D; Fakra E; Fossati P; Haffen E; Yrondi A; Hingray C
Encephale; 2022 Jun; 48(3):313-324. PubMed ID: 34876278
[TBL] [Abstract][Full Text] [Related]
5. Anticholinergic Burden and Dry Mouth in Middle-Aged People.
Tiisanoja A; Syrjälä AH; Kullaa A; Ylöstalo P
JDR Clin Trans Res; 2020 Jan; 5(1):62-70. PubMed ID: 31013461
[TBL] [Abstract][Full Text] [Related]
6. Xerostomia and medication: a cross-sectional study in long-term geriatric wards.
Desoutter A; Soudain-Pineau M; Munsch F; Mauprivez C; Dufour T; Coeuriot JL
J Nutr Health Aging; 2012; 16(6):575-9. PubMed ID: 22660000
[TBL] [Abstract][Full Text] [Related]
7. High anticholinergic burden and hyposalivation and xerostomia in the elderly.
Stenbäck J; Tiisanoja A; Syrjälä AM; Komulainen K; Hartikainen S; Ylöstalo P
Acta Odontol Scand; 2023 Aug; 81(6):436-442. PubMed ID: 36628441
[TBL] [Abstract][Full Text] [Related]
8. Anticholinergic burden of medications is associated with dry mouth and reflected in minor labial gland secretion.
Michail A; Almirza M; Alwaely F; Arany S
Arch Oral Biol; 2023 Dec; 156():105824. PubMed ID: 37865013
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of medication-induced xerostomia and effect of treatment.
Ito K; Izumi N; Funayama S; Nohno K; Katsura K; Kaneko N; Inoue M
PLoS One; 2023; 18(1):e0280224. PubMed ID: 36634078
[TBL] [Abstract][Full Text] [Related]
10. Anticholinergic effects of medication in elderly patients.
Tune LE
J Clin Psychiatry; 2001; 62 Suppl 21():11-4. PubMed ID: 11584981
[TBL] [Abstract][Full Text] [Related]
11. Anticholinergic Medication and Caries Status Predict Xerostomia under 65.
Cheah HL; Gray M; Aboelmagd S; Barmak AB; Arany S
Dent J (Basel); 2023 Mar; 11(4):. PubMed ID: 37185465
[TBL] [Abstract][Full Text] [Related]
12. Anticholinergic Medication Burden in Pediatric Prolonged Critical Illness: A Potentially Modifiable Risk Factor for Delirium.
Madden K; Hussain K; Tasker RC
Pediatr Crit Care Med; 2018 Oct; 19(10):917-924. PubMed ID: 30284995
[TBL] [Abstract][Full Text] [Related]
13. Drugs with anticholinergic side-effects in primary care.
Yayla EM; Yavuz E; Bilge U; Keskin A; Binen E
Niger J Clin Pract; 2015; 18(1):18-21. PubMed ID: 25511338
[TBL] [Abstract][Full Text] [Related]
14. Prevalence, risk factors and adverse outcomes of anticholinergic burden in patients with advanced chronic conditions at hospital admission.
Sevilla-Sánchez D; Molist-Brunet N; González-Bueno J; Solà-Bonada N; Espaulella-Panicot J; Codina-Jané C
Geriatr Gerontol Int; 2018 Aug; 18(8):1159-1165. PubMed ID: 29644803
[TBL] [Abstract][Full Text] [Related]
15. Size of the associations between anticholinergic burden tool scores and adverse outcomes in older patients.
Lavrador M; Cabral AC; Figueiredo IV; Veríssimo MT; Castel-Branco MM; Fernandez-Llimos F
Int J Clin Pharm; 2021 Feb; 43(1):128-136. PubMed ID: 32860598
[TBL] [Abstract][Full Text] [Related]
16. Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome.
Taylor-Rowan M; Edwards S; Noel-Storr AH; McCleery J; Myint PK; Soiza R; Stewart C; Loke YK; Quinn TJ
Cochrane Database Syst Rev; 2021 May; 5(5):CD013540. PubMed ID: 34097766
[TBL] [Abstract][Full Text] [Related]
17. Xerostomia and polypharmacy among dependent older New Zealanders: a national survey.
Thomson WM; Ferguson CA; Janssens BE; Kerse NM; Ting GS; Smith MB
Age Ageing; 2021 Jan; 50(1):248-251. PubMed ID: 32706865
[TBL] [Abstract][Full Text] [Related]
18. Anticholinergic Prescribing in Medicare Part D Beneficiaries Residing in Nursing Homes: Results from a Retrospective Cross-Sectional Analysis of Medicare Data.
Niznik J; Zhao X; Jiang T; Hanlon JT; Aspinall SL; Thorpe J; Thorpe C
Drugs Aging; 2017 Dec; 34(12):925-939. PubMed ID: 29214512
[TBL] [Abstract][Full Text] [Related]
19. Anticholinergic medications in community-dwelling older veterans: prevalence of anticholinergic symptoms, symptom burden, and adverse drug events.
Ness J; Hoth A; Barnett MJ; Shorr RI; Kaboli PJ
Am J Geriatr Pharmacother; 2006 Mar; 4(1):42-51. PubMed ID: 16730620
[TBL] [Abstract][Full Text] [Related]
20. Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community.
Bergler U; Ailabouni NJ; Pickering JW; Hilmer SN; Mangin D; Nishtala PS; Jamieson H;
Trials; 2021 Nov; 22(1):766. PubMed ID: 34732234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
